Back to 
CLIFFORD SWAN INVESTMENT COUNSEL LLC
CLIFFORD SWAN INVESTMENT COUNSEL LLC
AZN2 quarters
Position history for CLIFFORD SWAN INVESTMENT COUNSEL LLC's holdings in ASTRAZENECA PLC
No. Clifford Swan Investment Counsel exited its AZN (AstraZeneca) position in Q2 2026. Its Q1 2026 13F listed 1,034 shares worth $203,925. Clifford Swan Investment Counsel already held AZN in its Q1 2026 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$203,925
Total Shares Change
-1,034
Quarter-by-Quarter History
Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK